… for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project … -
B Fisher - J Natl Cancer I, 1998 - jnci.oxfordjournals.org
... ARTICLES. Tamoxifen for Prevention of Breast Cancer: Report of the National
Surgical Adjuvant Breast and Bowel Project P-1 Study. ...
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu … -
DJ Slamon, GM Clark, SG Wong, WJ Levin, A Ullrich, … - Science, 1987 - sciencemag.org
... Science articles. Human breast cancer: correlation of relapse and survival
with amplification of the HER-2/neu oncogene. DJ Slamon ...
… plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 -
DJ Slamon, B Leyland-Jones, S Shak, H Fuchs, V … - New England Journal of Medicine, 2001 - content.nejm.org
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast
Cancer That Overexpresses HER2. ... Adjuvant trastuzumab for breast cancer. ...
Gene expression profiling predicts clinical outcome of breast cancer -
LJ van't Veer, H Dai, MJ van de Vijver, YD He, AAM … - Nature, 2002 - Mass Med Soc
... Gene "Fingerprint" Improves Prognostic Accuracy in Breast Cancer. ... van 't Veer LJ
et al. Gene expression profiling predicts clinical outcome of breast cancer. ...
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families -
SA Narod, D Ford, P Devilee, RB Barkardottir, HT … - Am J Hum Genet, 1995 - pubmedcentral.nih.gov
... These families contain either a total of three or more cases of early-onset
(before age 60 years) breast cancer or ovarian cancer. ...
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. -
AE Giuliano, DM Kirgan, JM Guenther, DL Morton - Annals of Surgery, 1994 - pubmedcentral.nih.gov
... Copyright notice. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. ...
Controversies in primary breast cancer management. Am J Surg. ...
The effect of raloxifene on risk of breast cancer in postmenopausal women -
SR Cummings, S Eckert, KA Krueger, D Grady, TJ … - feedback, 2005 - biomedcentral.com
... Paper Report. The effect of raloxifene on risk of breast cancer in postmenopausal
women SR Cummings, S Eckert, KA Krueger, D Grady, TJ Powles, JA Cauley, L ...
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being … -
MH Gail, LA Brinton, DP Byar, DK Corle, SB Green, … - jnci, 1989 - jnci.oxfordjournals.org
... Press Projecting Individualized Probabilities of Developing Breast Cancer
for White Females Who Are Being Examined Annually. Mitchell ...
… antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after … -
MA Cobleigh, CL Vogel, D Tripathy - feedback, 2005 - biomedcentral.com
... study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women
who have HER2-overexpressing metastatic breast cancer that has progressed ...
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer -
MJ van de Vijver, YD He, LJ van't Veer, H Dai, AAM … - New England Journal of Medicine, 2002 - content.nejm.org
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer. Marc J.
van de Vijver, MD, Ph.D., Yudong D. He, Ph.D., Laura J. van 't Veer, Ph.D ...
Source: Google Scholar |